Innovative application of new MRI technology in evaluating therapeutic effect of traditional Chinese medicine for anal fistula

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000033072

Enrollment

Unknown

Registered

2020-05-19

Start date

2018-04-01

Completion date

Unknown

Last updated

2020-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anal Fistula

Interventions

Gold Standard:Surgical observation and pathological diagnosis.

Index test:MRI(perfusion-weighted&#32

imaging,diffusion-weighted&#32

imaging)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age of patients >= 18 years old; 2. Patients diagnosed as idiopathic cryptogenic anal fistula; 3. Patients who voluntarily participated in the study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with any contraindications of MRI; 2. The patient's compliance was poor and the examination could not be completed. (if any of the above criteria is met, it cannot be selected)

Design outcomes

Primary

Measure	Time frame
Perfusion MRI parameters;Diffusion MRI parameters;SEN, SPE, ACC, AUC of ROC;	—

Countries

China

Contacts

Public ContactHuang Bingcang

Gongli Hospital

hbc9209@163.com+86 13651899271

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026